Lower Costs For Drug Review Personnel Are “Completely Normal” – FDA
This article was originally published in The Tan Sheet
Executive Summary
While personnel costs fall in human drug reviews, non-personnel expenses increase. The changes could indicate FDA cost containment, but also come with another user fee increase.